Edition:
United States

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

613.20DKK
10:59am EDT
Change (% chg)

kr.-1.20 (-0.20%)
Prev Close
kr.614.40
Open
kr.613.40
Day's High
kr.614.20
Day's Low
kr.607.80
Volume
252,453
Avg. Vol
382,061
52-wk High
kr.617.20
52-wk Low
kr.474.30

Latest Key Developments (Source: Significant Developments)

Coloplast Launches Share Buy-Back Programme
Tuesday, 20 Feb 2018 04:44am EST 

Feb 20 (Reuters) - COLOPLAST ::REG-ANNOUNCEMENT NO. 3/2018 - SHARE BUYBACK PROGRAMME.IS LAUNCHING A SHARE BUY-BACK PROGRAMME OF UP TO DKK 1BN..‍FIRST PART OF PROGRAMME, OF DKK 500M, EXPECTED TO TAKE PLACE DURING PERIOD FROM 26 FEB 2018 TO 25 AUG 2018​.SECOND PART OF DKK 500M IS EXPECTED TO COMMENCE IN Q2 2018/19 AND BE COMPLETED BEFORE FINANCIAL YEAR END 2018/19.  Full Article

Coloplast Acquires IncoCare in Germany
Wednesday, 7 Feb 2018 06:31am EST 

Feb 7 (Reuters) - Coloplast A/S ::REG-COLOPLAST ACQUIRES INCOCARE GUNHILD VIELER GMBH.COLOPLAST - PURCHASE PRICE IS UNDISCLOSED..COLOPLAST - TRANSACTION WILL NOT IMPACT COLOPLAST'S FINANCIAL GUIDANCE FOR 17/18..  Full Article

Coloplast CFO Says Greek Authorities Have Reduced Prices In Our Segments By Around 25 Percent Final Price Settlement Due After Appeal Period
Thursday, 1 Feb 2018 08:13am EST 

Feb 1 (Reuters) - COLOPLAST CHIEF FINANCIAL OFFICER ANDERS LONNING-SKOVGAARD SAYS IN TELEPHONE INTERVIEW::GREEK AUTHORITIES HAVE REDUCED PRICES IN OUR SEGMENTS BY AROUND 25 PERCENT.FINAL PRICE SETTLEMENT IN GREECE DUE AFTER APPEAL PERIOD.  Full Article

Coloplast Q1 EBIT Below Expectations At DKK 1.21 Billion
Thursday, 1 Feb 2018 06:01am EST 

Feb 1 (Reuters) - COLOPLAST ::REG-ANNOUNCEMENT NO. 02/2018 - Q1 INTERIM FINANCIAL REPORT, 2017/18.Q1 REPORTED REVENUE IN DKK WAS UP BY 5% TO DKK 3,955M.‍CONTINUES TO EXPECT 2017/18 ORGANIC REVENUE GROWTH OF 7% AT CONSTANT EXCHANGE RATES​.Q1 EBIT DKK 1.21 BILLION (REUTERS POLL DKK 1.25 BILLION).Q1 REVENUE DKK 3.96‍​ BILLION (REUTERS POLL DKK 3.98 BILLION).Q1 PRETAX PROFIT DKK 1.22 BILLION (REUTERS POLL DKK 1.25 BILLION).  Full Article

Coloplast Acquires SAS Lilial
Monday, 18 Dec 2017 09:28am EST 

Dec 18 (Reuters) - Coloplast ::ANNOUNCEMENT NO. 13/2017 - COLOPLAST A/S ACQUIRES SAS LILIAL.TO ACQUIRE SAS LILIAL FOR A CASH CONSIDERATION OF EUR 35.5M EQUAL TO APPROX. DKK 264M ON A CASH AND DEBT-FREE BASIS​.‍TRANSACTION IS SUBJECT TO CUSTOMARY CLOSING CONDITIONS, AND IS EXPECTED TO CLOSE BEFORE YEAR-END 2017​.‍ACQUISITION WILL, IF COMPLETED, LEAD TO A REVISED FINANCIAL GUIDANCE FOR FINANCIAL YEAR 2017/18​.‍LILIAL IS EXPECTED TO RECORD SALES OF APPROX. EUR 33M OR APPROX. DKK 246M FOR FULL-YEAR 2017​.  Full Article

Coloplast CFO Buys 18,693 Shares In Company For Dkk 5,448,261.78‍​
Monday, 11 Dec 2017 05:26am EST 

Dec 11 (Reuters) - Coloplast ::CFO BUYS 18,693 SHARES IN COMPANY FOR DKK 5,448,261.78‍​.  Full Article

Coloplast sees 2017/2018 revenue growth at lower end of long-term outlook
Thursday, 2 Nov 2017 07:09am EDT 

Nov 2 (Reuters) - COLOPLAST :Q4 REVENUE DKK 3.98‍​ BILLION (REUTERS POLL DKK 4.02 BILLION).Q4 PRETAX PROFIT DKK ‍​1.33 BILLION (REUTERS POLL DKK 1.34 BILLION).‍EXPECT ORGANIC REVENUE GROWTH OF C7% AT CONSTANT EXCHANGE RATES.Q4 EBIT DKK ‍​1.32 BILLION (REUTERS POLL DKK 1.32 BILLION).‍EXPECTS IN 2017/2018 AN EBIT MARGIN OF 31-32% AT CONSTANT EXCHANGE RATES​.‍IN 2017/2018 CAPITAL EXPENDITURE IS EXPECTED TO BE ABOUT DKK 700M AND EFFECTIVE TAX RATE IS EXPECTED TO BE ABOUT 23%​.‍RECOMMENDS TO APPROVE A YEAR-END DIVIDEND OF DKK 10.5 PER SHARE.​.‍INTENDS TO PURSUE INORGANIC GROWTH OPPORTUNITIES TO FURTHER STRENGTHEN ITS SERVICE OFFERING TO CONSUMER​.COLOPLAST - LONG-TERM ‍ORGANIC REVENUE GROWTH GUIDANCE IS MAINTAINED AT 7-9% P.A. WHERE AMBITION IS TO REACH UPPER END OF INTERVAL​.COLOPLAST - LONG-TERM, ‍EBIT MARGIN GUIDANCE REVISED FROM 50-100BP IMPROVEMENT P.A., TO EBIT MARGIN OF >30% AT CONSTANT CURRENCIES​.  Full Article

Coloplast Q3 EBIT, revenue below forecast
Wednesday, 16 Aug 2017 05:57am EDT 

Aug 16 (Reuters) - COLOPLAST A/S :CONTINUE TO EXPECT 2016/17 ORGANIC REVENUE GROWTH OF 7-8% AT CONSTANT EXCHANGE RATES.Q3 REVENUE DKK 3.91‍​ BILLION (REUTERS POLL DKK 4.02 BILLION).Q3 EBIT DKK 1.23‍​ BILLION (REUTERS POLL DKK 1.33 BILLION).GUIDANCE FOR REPORTED 2016/17 REVENUE GROWTH IS REVISED TO 6% IN DKK INSTEAD OF AS PREVIOUSLY 7-8%.2016/17 EBIT MARGIN GUIDANCE REMAINS AT 33-34% AT CONSTANT EXCHANGE RATES.REPORTED 2016/17 EBIT MARGIN GUIDANCE IN DKK IS REVISED TO ABOUT 32% INSTEAD OF AS PREVIOUSLY ABOUT 33%.  Full Article

Coloplast Q2 revenue at DKK 3.88 BLN, in line with expectations
Wednesday, 3 May 2017 05:57am EDT 

May 3 (Reuters) - COLOPLAST ::H1 ORGANIC REVENUE GROWTH WAS 6%.RESOLVED THAT COLOPLAST WILL PAY AN INTERIM DIVIDEND OF DKK 4.50 PER SHARE FOR A DIVIDEND PAY-OUT OF DKK 955M.H1 REVENUE IN DKK WAS UP BY 5% TO DKK 7,636 MILLION."WE CONTINUE TO EXPECT ORGANIC REVENUE GROWTH OF 7-8% AT CONSTANT EXCHANGE RATES AND REPORTED GROWTH OF 7-8% IN DKK".BOARD HAS RESOLVED COLOPLAST WILL PAY INTERIM DIVIDEND OF DKK 4.50PER SHARE FOR DIVIDEND PAY-OUT OF DKK 955 MILLION.EBIT MARGIN GUIDANCE REMAINS AT 33-34% AT CONSTANT EXCHANGE RATES AND AT ABOUT 33% IN DKK.2016/17 CAPITAL EXPENDITURE IS STILL EXPECTED TO BE AROUND DKK 700M.CONTINUE TO EXPECT 2016/17 ORGANIC REVENUE GROWTH OF 7-8% AT CONSTANT EXCHANGE RATES AND REPORTED GROWTH OF 7-8% IN DKK.2016/17 EBIT MARGIN GUIDANCE REMAINS AT 33-34% AT CONSTANT EXCHANGE RATES AND AT ABOUT 33% IN DKK.H1 EBIT UP 8 PERCENT TO DKK 2.47 BILLION.COLOPLAST - FREE CASH FLOW WAS NEGATIVE AT DKK 648M, DKK 1,834M LESS THAN IN SAME PERIOD OF LAST YEAR.Q2 REVENUE DKK 3.88 BILLION (REUTERS POLL DKK 3.89 BILLION).Q2 EBIT DKK 1.25 BILLION (REUTERS POLL DKK 1.27 BILLION).  Full Article

Coloplast Q1 EBIT DKK 1.23 bln, in line with expectations
Wednesday, 1 Feb 2017 06:00am EST 

Coloplast A/S : Q1 organic revenue growth was 6 pct . Q1 revenue 3.76 billion Danish crowns ($545 million)(Reuters poll 3.76 billion crowns) . Q1 EBIT 1.23 billion crowns (Reuters poll 1.22 billion crowns) . Expects revenue growth of 7-8 pct at constant exchange rates and of 7-8 pct in Danish crowns in 2016/17 . Expects an EBIT margin of 33-34 pct, at constant exchange rates and of about 33 pct in Danish crownsin 2016/17 .2016/17 capital expenditure is expected to be about 700 million crowns.  Full Article

BRIEF-Coloplast Q2 EBIT at DKK 1.20 bln

* REG-ANNOUNCEMENT NO. 4/2018 - INTERIM FINANCIAL REPORT, H1 2017/18